Corcept Therapeutics SG&A Expense (Quarterly) Analysis

Corcept Therapeutics Inc (CORT)

24.52 -0.54 (-2.15%) USD | NASDAQ | May 03, 16:00

24.98 +0.46 (+1.88%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2003. Upgrade now.

Date	Value
December 31, 2023	47.15M
September 30, 2023	45.26M
June 30, 2023	43.28M
March 31, 2023	48.56M
December 31, 2022	42.32M
September 30, 2022	35.16M
June 30, 2022	37.81M
March 31, 2022	37.55M
December 31, 2021	32.28M
September 30, 2021	30.53M
June 30, 2021	30.03M
March 31, 2021	29.51M
December 31, 2020	25.70M
September 30, 2020	26.52M
June 30, 2020	25.57M
March 31, 2020	27.54M
December 31, 2019	27.13M
September 30, 2019	24.24M
June 30, 2019	24.59M
March 31, 2019	24.39M
December 31, 2018	21.56M
September 30, 2018	21.31M
June 30, 2018	19.98M
March 31, 2018	18.44M
December 31, 2017	16.80M

Date	Value
September 30, 2017	16.47M
June 30, 2017	14.11M
March 31, 2017	15.04M
December 31, 2016	11.76M
September 30, 2016	10.93M
June 30, 2016	12.12M
March 31, 2016	10.43M
December 31, 2015	8.863M
September 30, 2015	9.291M
June 30, 2015	9.342M
March 31, 2015	9.453M
December 31, 2014	8.044M
September 30, 2014	9.103M
June 30, 2014	7.965M
March 31, 2014	9.805M
December 31, 2013	7.517M
September 30, 2013	7.179M
June 30, 2013	8.16M
March 31, 2013	8.383M
December 31, 2012	6.482M
September 30, 2012	5.694M
June 30, 2012	5.751M
March 31, 2012	7.487M
December 31, 2011	3.282M
September 30, 2011	3.209M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

24.24M

Minimum

Sep 2019

48.56M

Maximum

Mar 2023

33.72M

Average

30.53M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks